Latest From Diagnostica Stago
Are medtech regulators and authorities in wider Europe – including Russia – setting market access barriers too high, risking investment in innovation and potentially denying patients access to modern care? European Diagnostic Manufacturers Association (EDMA) representative Christian Parry fears so, in this second half of our industry update from the 2015 European MedTech Forum.
There is a need for assays to help guide therapy with the growing number of anticoagulant drugs on the market, but without clearer FDA guidelines development will be a challenge, companies and labs tell the agency.
The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
- In Vitro Diagnostics
- Therapeutic Areas
- Blood & Coagulation Disorders & Products
- Western Europe
- Parent & Subsidiaries
- Diagnostica Stago
- Senior Management
- Lionel Viret, Pres.
- Contact Info
Phone: (33) 1 46 88 20 20
9, rue des Frères Chausson
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.